Hemoglobinopathies
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
||
Data: |
|
||
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Registry and Surveillance System for Hemoglobinopathies (RuSH), NIH |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
Bleeding and Clotting
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
Universal Data Collection System (UDC), CDC/NCBDDD |
Revision History: | History is not available. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Baseline: | 54.3 persons per 10,000 population aged 18 years and older developed venous thromboembolism (VTE) in 2007 (age adjusted to the year 2000 standard population) | ||||
Target: | 48.9 per 10,000 population | ||||
Target-Setting Method: | 10 percent improvement | ||||
Potential Data Sources: |
National Ambulatory Medical Care Survey (NAMCS), CDC/NCHS; National Hospital Ambulatory Medical Care Survey (NHAMCS), CDC/NCHS |
||||
Data: |
|
||||
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
National Hospital Discharge Survey (NHDS), CDC/NCHS |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
Potential Data Sources: |
National Hospital Discharge Survey (NHDS), CDC/NCHS |
This objective was archived due to lack of data source, changes in science, or was replaced with other objectives. See Revision History for Details.
Potential Data Sources: |
To be determined |
Revision History: | This objective was archived due to lack of a viable data source. Read more about the revision history. |
This objective was revised. See Revision History for Details.
Baseline: | 69.7 percent of persons with von Willebrand disease (VWD) who were seen in a specialty care center were diagnosed by 21 years of age in 2012 | ||||
Target: | 76.7 percent | ||||
Target-Setting Method: | 10 percent improvement | ||||
Data Sources: |
Community Counts Hemophilia Treatment Centers Population Profile (HTC Population Profile), CDC/NCBDDD and ATHN |
||||
Data: |
|
||||
Revision History: | This objective was revised. Read more about the revision history. |
This objective was revised. See Revision History for Details.
Baseline: | 15.9 percent of persons with severe hemophilia experienced more than four joint bleeds in 2015 | ||||||
Target: | 14.3 percent | ||||||
Target-Setting Method: | 10 percent improvement | ||||||
Data Sources: |
Community Counts Registry for Bleeding Disorders Surveillance (Community Counts Registry), CDC/NCBDDD and ATHN |
||||||
Data: |
|
||||||
Revision History: | This objective was revised. Read more about the revision history. |
Blood Safety
Baseline: | 6.1 percent of the population aged 18 years and over reported donating blood within the past year in 2008 (age adjusted to the year 2000 standard population) | ||||||||
Target: | 6.7 percent | ||||||||
Target-Setting Method: | 10 percent improvement | ||||||||
Data Sources: |
National Health Interview Survey (NHIS), CDC/NCHS |
||||||||
Data: |
|
Potential Data Sources: |
National Blood Collection and Utilization Survey (NBCUS), DHHS |
Potential Data Sources: |
National Blood Collection and Utilization Survey (NBCUS), DHHS |
Potential Data Sources: |
National Blood Collection and Utilization Survey (NBCUS), DHHS |
Potential Data Sources: |
To be determined |
Potential Data Sources: |
National Blood Collection and Utilization Survey (NBCUS), DHHS |
Potential Data Sources: |
National Blood Collection and Utilization Survey (NBCUS), DHHS |
Potential Data Sources: |
National Blood Collection and Utilization Survey (NBCUS), DHHS |